Repeat Interventions After Transcatheter Aortic Valve Replacement: Considerations for Lifetime Management-The First Cut Is the Deepest.
作者信息
Goel Sachin S, Galper Benjamin Z
机构信息
Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas, USA.
Mid-Atlantic Permanente Medical Group, McLean, Virginia, USA.
出版信息
Struct Heart. 2025 Feb 15;9(5):100426. doi: 10.1016/j.shj.2025.100426. eCollection 2025 May.
Abstract
摘要
相似文献
1
Repeat Interventions After Transcatheter Aortic Valve Replacement: Considerations for Lifetime Management-The First Cut Is the Deepest.经导管主动脉瓣置换术后的重复干预：终身管理的考量——首次切割最为深刻。
Struct Heart. 2025 Feb 15;9(5):100426. doi: 10.1016/j.shj.2025.100426. eCollection 2025 May.
2
Repeat Interventions After Transcatheter Aortic Valve Replacement: Clinical Characteristics and Outcomes of Redo Transcatheter Aortic Valve Replacement and Surgical Explants.经导管主动脉瓣置换术后的重复干预：再次经导管主动脉瓣置换术和外科取出术的临床特征及结果
Struct Heart. 2025 Jan 17;9(5):100393. doi: 10.1016/j.shj.2024.100393. eCollection 2025 May.
3
Clinical Characteristics and Outcomes of Patients Undergoing 3 Aortic Valve Interventions: The THIRD Multicenter Registry.接受3种主动脉瓣干预治疗患者的临床特征与结局：THIRD多中心注册研究
JACC Cardiovasc Interv. 2025 Jan 13;18(1):103-115. doi: 10.1016/j.jcin.2024.10.037.
4
Long-term outcomes of transapical-transcatheter aortic valve replacement.经心尖经导管主动脉瓣置换术的长期预后
Gen Thorac Cardiovasc Surg. 2024 Oct 23. doi: 10.1007/s11748-024-02095-x.
5
Lifetime Strategy of Patients With Aortic Stenosis: The First Cut Is the Deepest.主动脉瓣狭窄患者的终身策略：首次干预最为关键。
JACC Cardiovasc Interv. 2021 Aug 9;14(15):1727-1730. doi: 10.1016/j.jcin.2021.06.029.
6
Sex-Related Differences in Postoperative Outcomes After Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis.经导管主动脉瓣置换术后性别相关结局差异：系统评价和荟萃分析。
Cardiol Rev. 2024;32(1):30-44. doi: 10.1097/CRD.0000000000000448. Epub 2022 Mar 15.
7
Prevalence and Management of Multiple Valvular Heart Disease in Patients Undergoing Transcatheter Aortic Valve Replacement: A Multicenter Study on the Impact of Staged Valvular Interventions on Outcomes.经导管主动脉瓣置换术患者中多瓣膜心脏病的患病率及管理：关于分期瓣膜干预对结局影响的多中心研究
J Am Heart Assoc. 2025 Jun 17;14(12):e040150. doi: 10.1161/JAHA.124.040150. Epub 2025 Jun 5.
8
Surgical Bailout in Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement: Incidence, Trends, and Clinical Outcomes.经股动脉经导管主动脉瓣置换术患者的外科补救措施：发生率、趋势及临床结果
JACC Cardiovasc Interv. 2025 Jan 13;18(1):89-99. doi: 10.1016/j.jcin.2024.09.050.
9
Impact of Calcified Raphe on TAVR in Bicuspid Patients: Predicting Redo-TAVR Feasibility and Virtual Planning Implications.钙化中隔对二叶式患者经导管主动脉瓣置换术的影响：预测再次经导管主动脉瓣置换术的可行性及虚拟规划的意义
Circ Cardiovasc Interv. 2025 Jun;18(6):e014802. doi: 10.1161/CIRCINTERVENTIONS.124.014802. Epub 2025 Apr 22.
10
Transcatheter closure of an ascending aortic pseudoaneurysm using an atrial septal defect occluder: a case report.使用房间隔缺损封堵器经导管闭合升主动脉假性动脉瘤：一例报告
Egypt Heart J. 2025 Jun 16;77(1):62. doi: 10.1186/s43044-025-00663-x.
本文引用的文献
1
Outcomes of repeat transcatheter aortic valve replacement with balloon-expandable valves: a registry study.重复经导管主动脉瓣置换术使用球囊扩张瓣的结果：注册研究。
Lancet. 2023 Oct 28;402(10412):1529-1540. doi: 10.1016/S0140-6736(23)01636-7. Epub 2023 Aug 31.
2
Redo Surgical Aortic Valve Replacement After Prior Transcatheter Versus Surgical Aortic Valve Replacement.既往经导管主动脉瓣置换术后再次行外科主动脉瓣置换术与初次外科主动脉瓣置换术的比较
JACC Cardiovasc Interv. 2023 Apr 24;16(8):942-953. doi: 10.1016/j.jcin.2023.03.015.
3
Explant vs Redo-TAVR After Transcatheter Valve Failure: Mid-Term Outcomes From the EXPLANTORREDO-TAVR International Registry.经导管瓣膜失效后取出瓣膜与再次经导管主动脉瓣置换术：EXPLANTORREDO-TAVR国际注册研究的中期结果
JACC Cardiovasc Interv. 2023 Apr 24;16(8):927-941. doi: 10.1016/j.jcin.2023.01.376.
4
Indication Creep in Transcatheter Aortic Valve Implantation-Data or Desire?经导管主动脉瓣植入术中的适应症蔓延——是数据还是需求？
JAMA Cardiol. 2023 Jun 1;8(6):519-520. doi: 10.1001/jamacardio.2023.0674.
5
National Trends in TAVR and SAVR for Patients With Severe Isolated Aortic Stenosis.严重单纯性主动脉瓣狭窄患者经导管主动脉瓣置换术（TAVR）和外科主动脉瓣置换术（SAVR）的全国趋势
J Am Coll Cardiol. 2022 Nov 22;80(21):2054-2056. doi: 10.1016/j.jacc.2022.08.787. Epub 2022 Sep 16.
6
Outcomes of Redo Transcatheter Aortic Valve Replacement According to the Initial and Subsequent Valve Type.根据初始和后续瓣膜类型评估经导管主动脉瓣置换术的再手术结果。
JACC Cardiovasc Interv. 2022 Aug 8;15(15):1543-1554. doi: 10.1016/j.jcin.2022.05.016. Epub 2022 Jul 13.
7
Surgical Explantation After TAVR Failure: Mid-Term Outcomes From the EXPLANT-TAVR International Registry.经导管主动脉瓣置换术（TAVR）失败后的外科取出：EXPLANT-TAVR 国际注册研究的中期结果。
JACC Cardiovasc Interv. 2021 Sep 27;14(18):1978-1991. doi: 10.1016/j.jcin.2021.07.015.
8
Aortic valve reintervention in patients with failing transcatheter aortic bioprostheses: A statewide experience.经导管主动脉生物瓣膜功能衰竭患者的主动脉瓣再次干预：一项全州范围的经验。
J Thorac Cardiovasc Surg. 2023 Jun;165(6):2011-2020.e5. doi: 10.1016/j.jtcvs.2021.08.057. Epub 2021 Aug 31.
9
Nationally Representative Repeat Transcatheter Aortic Valve Replacement Outcomes: Report From the Centers for Medicare and Medicaid Services.全国代表性重复经导管主动脉瓣置换术结果：来自医疗保险和医疗补助服务中心的报告。
JACC Cardiovasc Interv. 2021 Aug 9;14(15):1717-1726. doi: 10.1016/j.jcin.2021.06.011.
10
Surgical Explantation of Transcatheter Aortic Valve Bioprostheses: A Statewide Experience.经导管主动脉瓣生物瓣假体的外科取出术：全州范围的经验。
Circ Cardiovasc Interv. 2021 Apr;14(4):e009927. doi: 10.1161/CIRCINTERVENTIONS.120.009927. Epub 2021 Mar 15.
Zotero 插件